Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,865 across all filing types
Latest filing 2023-12-01 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company Yifeng Pharmacy Chain Co., Ltd. regarding the repayment of temporarily used convertible bond funds that were used to supplement working capital. It details amounts used, repaid, and remaining balances, and references previous announcements. The content focuses on capital usage and repayment updates related to convertible bonds, which is a financing activity. The document length is short (800 characters) and it is an announcement of a capital/financing update rather than a full financial report or audit. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-12-01 Chinese
益丰药房关于向不特定对象发行可转换公司债券申请获得上海证券交易所上市审核委员会审议通过的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the approval by the Shanghai Stock Exchange Listing Review Committee for the company's application to issue convertible bonds to unspecified investors. It mentions the need for further approval by the China Securities Regulatory Commission before implementation. The content focuses on a capital raising activity and related regulatory approvals, not on financial results or detailed financial statements. The document length is short (603 characters) and it is clearly an update on financing activity rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2023-11-17 Chinese
益丰药房关于回复上海证券交易所《关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的审核中心意见落实函》的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the receipt of a regulatory review letter from the Shanghai Stock Exchange about the company's application to issue convertible bonds to unspecified investors. It mentions the submission of related documents and the need for further approvals from the exchange and the China Securities Regulatory Commission. The document is short (788 characters) and serves as an update on the status of a financing activity, not the actual issuance or detailed financial report. Therefore, it fits best under Capital/Financing Update (CAP).
2023-11-10 Chinese
益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券之证券募集说明书(上会稿)
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书" which translates to a "Prospectus" or "Offering Circular" for the issuance of convertible corporate bonds by Yifeng Pharmacy Chain Co., Ltd. It contains detailed information about the bond issuance, including the nature of the convertible bonds, credit ratings, risk factors, company governance, financial data, and investment projects. It is a comprehensive disclosure document related to capital raising through convertible bonds. This type of document is a capital/financing update rather than a financial report, earnings release, or regulatory filing. It is not an announcement of a report but the actual offering document. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2023-11-10 Chinese
天健会计师事务所(特殊普通合伙)关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的审计报告及财务报告
Regulatory Filings
2023-11-10 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) issued by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) regarding the issuance of convertible bonds by 益丰大药房连锁股份有限公司 (Yifeng Pharmacy Chain Co., Ltd.). It is a detailed sponsorship letter related to the issuance of convertible corporate bonds to unspecified investors. The document includes sections on the sponsor's commitments, legal and regulatory compliance, due diligence, internal review procedures, and the basic information about the issuer and the bond issuance. It is not a financial report like an annual or interim report, nor is it an earnings release or a call transcript. It is also not a proxy statement, voting results, or a director dealing report. The document is a formal issuance sponsorship letter, which is a type of capital/financing update related to fundraising activities and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed substantive content, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high due to the clear nature and content of the document.
2023-11-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.